Bristol Myers Squibb to Invest $40B in the US Over 5 Years

Bristol Myers Squibb announced it will invest $40B in the US over the next five years to expand its research and manufacturing presence. With facilities in Seattle and Bothell, Bristol Myers Squibb’s commitment to US-based innovation bolsters Washington state’s life science sector, particularly in oncology, hematology and immunology.